The protective effect and underlying mechanism of metformin on neointima formation in fructose-induced insulin resistant rats
Open Access
- 5 April 2013
- journal article
- Published by Springer Nature in Cardiovascular Diabetology
- Vol. 12 (1) , 58
Abstract
Background: Insulin resistance is strongly associated with the development of type 2 diabetes and cardiovascular disease. However, the underlying mechanisms linking insulin resistance and the development of atherosclerosis have not been fully elucidated. Moreover, the protective effect of antihyperglycemic agent, metformin, is not fully understood. This study investigated the protective effects and underlying mechanisms of metformin in balloon-injury induced stenosis in insulin resistant rats. Methods: After 4 weeks high fructose diet, rats received balloon catheter injury on carotid arteries and were sacrificed at 1 and 4 weeks post injury. Biochemical, histological, and molecular changes were investigated. Results: Plasma levels of glucose, insulin, total cholesterol, triglyceride, free fatty acids, and methylglyoxal were highly increased in fructose-induced insulin resistant rats and treatment with metformin significantly improved this metabolic profile. The neointimal formation of the carotid arteries was enhanced, and treatment with metformin markedly attenuated neointimal hyperplasia. A significant reduction in BrdU-positive cells in the neointima was observed in the metformin-treated group (P < 0.01). Insulin signaling pathways were inhibited in insulin resistant rats while treatment with metformin enhanced the expression of insulin signaling pathways. Increased expression of JNK and NFKB was suppressed following metformin treatment. Vasoreactivity was impaired while treatment with metformin attenuated phenylephrine-induced vasoconstriction and enhanced methacholine-induced vasorelaxation of the balloon injured carotid arteries in insulin resistant rats. Conclusion: The balloon-injury induced neointimal formation of the carotid arteries is enhanced by insulin resistance. Treatment with metformin significantly attenuates neointimal hyperplasia through inhibition of smooth muscle cell proliferation, migration, and inflammation as well as by improvement of the insulin signaling pathway.Keywords
This publication has 39 references indexed in Scilit:
- Increased plasma methylglyoxal level, inflammation, and vascular endothelial dysfunction in diabetic nephropathyClinical Biochemistry, 2011
- Modulation of methylglyoxal and glutathione by soybean isoflavones in mild streptozotocin-induced diabetic ratsNutrition, Metabolism and Cardiovascular Diseases, 2008
- Mechanisms linking obesity with cardiovascular diseaseNature, 2006
- Insulin resistance and atherosclerosisJournal of Clinical Investigation, 2006
- Neointimal hyperplasia and vascular endothelial growth factor expression are increased in normoglycemic, insulin resistant, obese fatty ratsAtherosclerosis, 2006
- Methylglyoxal administration induces diabetes-like microvascular changes and perturbs the healing process of cutaneous woundsClinical Science, 2005
- Insulin stimulates arterial neointima formation in normal rats after balloon injuryDiabetes, Obesity and Metabolism, 2005
- Neointimal Hyperplasia After Arterial Injury Is Increased in a Rat Model of Non–Insulin-Dependent Diabetes MellitusCirculation, 2001
- Methylglyoxal in living organismsToxicology Letters, 1999
- Metformin reduces systemic methylglyoxal levels in type 2 diabetes.Diabetes, 1999